LITS
Lite Strategy, Inc.NASDAQHealthcare$1.12+1.79%ClosedMarket Cap: $41.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.09
P/S
0.00
EV/EBITDA
-2.62
DCF Value
$2.68
FCF Yield
-29.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-68.9%
ROA
-47.9%
ROIC
-14.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $0.00 | NaN% | $-3.4M | $-30.8M | $-4.62 | — |
| Q1 2026 | $0.00 | NaN% | $-3.0M | $-3.6M | $-0.55 | — |
| Q4 2025 | $0.00 | NaN% | $-2.9M | $-2.7M | $-0.40 | — |
| FY 2025 | $0.00 | -Infinity% | $-17.5M | $-15.9M | $-2.39 | — |
| Q3 2025 | $0.00 | NaN% | $-2.8M | $-2.6M | $-0.39 | — |
| Q2 2025 | $0.00 | NaN% | $-3.5M | $-2.7M | $-0.40 | — |
| Q1 2025 | $0.00 | -Infinity% | $-8.4M | $-8.0M | $-1.20 | — |
| Q4 2024 | $0.00 | -Infinity% | $-8.1M | $-18.4M | $-2.76 | — |
| FY 2024 | $65.3M | 100.0% | $14.5M | $17.8M | $2.67 | $1.75 |
| Q3 2024 | $0.00 | -Infinity% | $-9.8M | $-9.1M | $-1.37 | — |
| Q2 2024 | $0.00 | -Infinity% | $-11.9M | $-11.1M | $-1.66 | $1.75 |
| FY 2023 | $48.8M | 100.0% | $-36.8M | $-31.8M | $-4.78 | — |